Skip to content
Dx

ICD-10-PCS 2027 procedure code

3E0J805Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

✓ Valid for 2027

Short description: Introduction of Oth Antineoplastic into Bil/Panc Tract, Endo

Code unchanged since ICD-10-PCS took effect on October 1, 2015. Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About 3E0J805

3E0J805 is the ICD-10-PCS code for a introduction procedure on the biliary and pancreatic tract using a via natural or artificial opening endoscopic approach with antineoplastic (qualifier: other antineoplastic). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

In plain terms, this corresponds to implantation of chemotherapeutic agent, the ICD-9-CM procedure title it maps to (00.10).

For a different body part, codes include 3E0E805 (products of conception), 3E0F805 (respiratory tract), 3E0G805 (upper GI), 3E0H805 (lower GI), 3E0K805 (genitourinary tract), 3E0N805 (male reproductive) and 1 more.

The same procedure with a different approach is coded 3E0J305 (percutaneous) and 3E0J705 (via natural or artificial opening).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It has been valid since ICD-10-PCS took effect on October 1, 2015.

What each character means

1. Section
3Administration
2. Body System
EPhysiological Systems and Anatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body System / Region
JBiliary and Pancreatic Tract
5. Approach
8Via Natural or Artificial Opening Endoscopic

Entry of instrumentation through a natural or artificial external opening to reach and visualize the site of the procedure

6. Substance
0Antineoplastic

Includes: Amivantamab Monoclonal Antibody; Lurbinectedin; RYBREVANT (tm) (Amivantamab Monoclonal Antibody); ZEPZELCA(tm) (Lurbinectedin)

7. Qualifier
5Other Antineoplastic

Other versions of this procedure

ICD-9-CM equivalent

Converter →
  • 00.10Implantation of chemotherapeutic agentapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about 3E0J805

Is 3E0J805 a valid ICD-10-PCS code for 2027?

Yes. 3E0J805 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

What is the ICD-9 procedure code for 3E0J805?

The CMS GEMs map 3E0J805 to ICD-9-CM 00.10 (Implantation of chemotherapeutic agent).